| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2024 | Association of Muscle Mass Loss with Diabetes Development in Liver Transplantation Recipients
| DIABETES & METABOLISM JOURNAL |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
| DIABETES & METABOLISM JOURNAL |
| 2023 | Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
| DIABETES & METABOLISM |
| 2023 | β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 8 months | DIABETES & METABOLISM |
| 2023 | Machine-learning enhancement of urine dipstick tests for chronic kidney disease detection | JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018
| NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
| 2022 | Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
| DIABETES & METABOLISM JOURNAL |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | The effects of the voglibose on non-alcoholic fatty liver disease in mice model
| SCIENTIFIC REPORTS |
| 2022 | Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
| 2022 | Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | Targeting PLD2 in adipocytes augments adaptive thermogenesis by improving mitochondrial quality and quantity in mice
| JOURNAL OF EXPERIMENTAL MEDICINE |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
| DIABETES & METABOLISM JOURNAL |
| 2021 | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
| Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Association between domain-specific physical activity and diabetes in Korean adults
| SCIENTIFIC REPORTS |
| 2021 | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | DIABETES OBESITY & METABOLISM |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2020 | Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2020 | Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
| BIOMEDICINES |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
| 2020 | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2020 | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
| CARDIOVASCULAR DIABETOLOGY |
| 2020 | SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease
| NATURE COMMUNICATIONS |
| 2020 | Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo
| JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS |
| 2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
| 2020 | Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2020 | Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study) | DIABETES OBESITY & METABOLISM |
| 2020 | Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
| Journal of Lipid and Atherosclerosis |
| 2020 | Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2020 | Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules | DIABETES OBESITY & METABOLISM |
| 2020 | Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
| JOURNAL OF CLINICAL MEDICINE |
http://orcid.org/0000-0002-0364-4675
(7201795697)
